A Standing Dilemma: Autonomic Failure Preceding Hodgkin's Lymphoma - 22/03/14

Doi : 10.1016/j.amjmed.2013.12.002

Cyndya Shibao, MD ^a,^c, Prasuna Muppa, MBBS ^a, Matthew W. Semler, MD ^b, Amanda C. Peltier, MD ^d, Italo Biaggioni, MD ^a,^c,^⁎
^a Division of Clinical Pharmacology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tenn
^b Division of Allergy, Pulmonary, and Critical Care Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tenn
^c Autonomic Dysfunction Center, Vanderbilt University Medical Center, Nashville, Tenn
^d Department of Neurology, Vanderbilt University Medical Center, Nashville, Tenn

^∗Requests for reprints should be addressed to Italo Biaggioni, MD, Professor of Medicine, Division of Clinical Pharmacology, Vanderbilt University, 556 RRB, Nashville, TN 37232.

El texto completo de este artículo está disponible en PDF.

Aimee K. Zaas, MD, Section Editor

El texto completo de este artículo está disponible en PDF.

Esquema

	Funding: None.
	Conflict of Interest: None.
	Authorship: All authors had access to the data. All the authors declared that they met criteria for authorship including acceptance of responsibility for the scientific content of the manuscript.
	CS receives funding from the American Heart Association, Clinical Research Program 10CRP4310026, National Institute of Health (NIH) grant K23 HL103976-02, and by a Pharmaceutical Research and Manufacturers of America Foundation Career Development Award. The study was supported in part by the Vanderbilt Clinical and Translational Science Award grant 5UL1 RR024975-03 from the National Center for Research Resources/NIH.